• Corpus ID: 82477646

Tumor inhibition by titanocene complexes: Influence upon two xenografted human lung carcinomas

  title={Tumor inhibition by titanocene complexes: Influence upon two xenografted human lung carcinomas},
  author={P. Kiipf-Maier},
The influence of the organometallic complexes titanocene dichloride, titanocene dibromide, titanocene bis(hydrogenmaleinate), and titanocene bis(p-aminothiophenolate) bis(hydrochloride) on the development of a lung adenocarcinoma and a small cell lung carcinoma, both xenografted into athymic mice, was investigated in the present study. The tumors were growing s.c., and the substances administered i.p. as fivefold injections according to a Q2D x 5 (every 2 days x 5) or a Q3D x 5 schedule. In the… 

Tables from this paper

Antitumor activity of treosulfan in human lung carcinomas
The present study confirms the pronounced and significant antitumor activity of treosulfan against heterotransplanted human lung carcinomas of both the small-cell and the non-small-cell type and should be followed rapidly by phase II clinical trials.
Apoptosis-inducing vanadocene compounds against human testicular cancer.
Vanadocenes, especially the lead compound VCp2(NCSe)2, may be useful in the treatment of testicular cancer because of their cytotoxic effects.
Histologic and ultrastructural alterations of a xenografted human colon adenocarcinoma after treatment with titanocene dichloride
  • P. Köpf-Maier
  • Biology, Medicine
    Journal of Cancer Research and Clinical Oncology
  • 2004
The results confirm the tumor-inhibiting potency of titanocene dichloride against human colon adenocarcinoma and underline the discriminatory power of morphologic studies in the preclinical evaluation of cytostatic drugs against heterotransplanted human tumors.
Phase II trial of titanocene dichloride in advanced renal-cell carcinoma
Titanocene dichloride has no advantage in the therapy of RCC and was capable of inhibiting the growth of different types of human tumors in vitro.
Metal Compounds in Cancer Therapy
  • S. Fricker
  • Materials Science
    Springer Netherlands
  • 1994
Introduction, S.P. Fricker. Platinum Anti-Cancer Drugs L.R. Kelland. Gold, F. Shaw III. Ruthenium Compound in Cancer Therapy, G. Sava. Rhodium, Iridium and Palladium Compounds as Experimental